The Real Reason Google Knocks Back GLP-1 Ads
We have run GLP-1 ad campaigns on Google for compounding pharmacies since 2023. Every single account we take over has the same problem: the ads get rejected within 24 hours and nobody can tell you exactly why. The disapproval notice says "healthcare and medicines" but never spells out what that actually means for a compounding pharmacy.
Here is what we learned the hard way. Google does not reject GLP-1 ads because the compound is illegal. It rejects them because the advertiser never completed the certification Google requires, and the landing page almost always violates the healthcare policy in ways the pharmacy never considered.
The Certification Problem Nobody Talks About
Google requires advertisers in the healthcare space to complete its healthcare and medicines certification before running any ads related to prescription drug conditions. This includes GLP-1 receptor agonists. If you skip this step, which most pharmacies do because they do not know it exists, every ad gets auto-rejected before a human ever looks at it.
The certification process asks for your pharmacy license, your NPI number, and a declaration that you operate legally under FDA compounding rules. If you leave any field blank or upload an expired license, the certification fails silently. You will not get an email telling you why. Your ads just keep getting rejected.
Landing Page Triggers That Tank Approvals
Even with certification, your landing page can get you banned. Google scans every page your ad links to for what it calls "prescription drug content." Here is what triggers the flag:
Dosing instructions. Any mention of how much to take, how often to inject, or titration schedules gets flagged as unapproved prescribing guidance. Remove every dosing reference from your landing page.
Branded drug names. Using Ozempic, Wegovy, or Mounjaro in your page copy triggers Google's trademark policy and its healthcare policy simultaneously. Even if you are comparing compounded versions to branded drugs, the bots do not parse context. They see the name and reject.
Weight loss claims. Stating or implying weight loss results, average pounds lost, or before-and-after language will get the ad rejected under Google's personal hardship policy. This policy prohibits ads that imply a negative self-perception and promise a transformation.
Prescription requirement missing. Your landing page must clearly state that compounded GLP-1 medications require a valid prescription and are dispensed through a licensed pharmacy. If this language is buried in the footer, Google's review system treats it as absent.
What Google Expects From FDA 503A and 503B
Google's policy references FDA compounding regulations indirectly through its healthcare policy requirement that all ads be truthful and compliant with applicable laws. For GLP-1 compounding, the applicable laws are FDA 503A and 503B.
FDA 503A covers traditional compounding pharmacies that prepare medications for individual patients with a valid prescription. If you operate under 503A, your ads must not imply mass production, stock availability, or any suggestion that compounded GLP-1s are a consumer product. Your messaging must center on the patient-practitioner-pharmacy relationship.
FDA 503B covers outsourcing facilities that compound at larger scale. If you hold a 503B registration, include language about cGMP compliance, sterile compounding standards, and batch-level quality testing. Google's reviewers, when they escalate to a human, check for these distinctions.
How We Get GLP-1 Ads Approved on Google
Complete the healthcare certification first. Before writing a single ad, apply for Google's healthcare and medicines certification. You need your pharmacy license, NPI, and a statement of legal operation. Plan on a 3 to 5 business day review. Ads submitted before certification is live will be rejected regardless of content.
Audit your landing page for the four triggers. Strip dosing information, branded drug names, weight loss claims, and make the prescription requirement visible above the fold. Every page you plan to link from an ad needs this audit.
Use service-oriented keywords. Instead of "buy semaglutide" or "Ozempic alternative," target "compounded weight management consultation" and "GLP-1 therapy evaluation." These keywords signal medical service, not drug sales, to Google's classification engine.
Pre-write your appeal documentation. When you appeal a rejection, attach your healthcare certification approval, your pharmacy license, and a one-page compliance summary explaining which FDA framework you operate under and how your ads comply. We have seen this cut appeal resolution time from weeks to days.
A Compounding Pharmacy Got Approved in 11 Days
We worked with a 503A compounding pharmacy in Texas that wanted to run Google Ads for their GLP-1 compounding program. Their first batch of six ads was rejected in under 12 hours. The rejection notice gave no specifics beyond the healthcare policy reference.
We immediately pulled all ads and audited their landing page. The page mentioned Ozempic and Wegovy in three places, included a dosage chart for semaglutide, and had the prescription disclaimer visible only after scrolling. All three triggers were live.
We removed every branded drug reference, deleted the dosing chart, moved the prescription disclaimer to the hero section, and rebuilt the keyword list around consultations and evaluations. We also completed their healthcare certification, which had been sitting half-finished for two months because nobody knew it was a requirement.
Eleven days after the initial rejection, all six ads were approved and live. The pharmacy ran those ads for eight months without a single additional rejection. The difference was not the ad copy. It was the certification and the landing page structure.
Why BAV Matters for Google Ads
The Business Asset Verification pathway, more commonly associated with Meta, has an indirect effect on Google approvals. Google's advertiser verification program cross-references business legitimacy signals. A verified business with consistent documentation across platforms gets fewer automated flags. If you have completed BAV on Meta, reference that same business documentation in your Google healthcare certification. Consistency reduces friction.
Read These Next
If your GLP-1 ads are also getting banned on Meta, read our Facebook appeal playbook. For the broader peptide compliance picture, peptide advertising regulations covers FDA frameworks across all platforms.
Ready to run these ads? Book a call → calendly.com/custodio-2/30min